DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 KDMF, 1 Listed Suppliers

1 API Suppliers
1 KDMF
1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

16 FDF Dossiers, 5 FDA Orange Book, 5 Canada, 6 Australia

16 FDF Dossiers
5 FDA Orange Book
5 Canada
6 Australia

DRUG PRODUCT COMPOSITIONS

FOR SUSPENSION;INTRAMUSCULAR - EQ 10MG BASE/VIAL, FOR SUSPENSION;INTRAMUSCULAR - EQ 20MG BASE/VIAL, FOR SUSPENSION;INTRAMUSCULAR - EQ 30MG BASE/VIAL, FOR SUSPENSION;INTRAMUSCULAR - EQ 40MG BASE/VIAL, FOR SUSPENSION;INTRAMUSCULAR - EQ 60MG BASE/VIAL

drugProductComposition
FOR SUSPENSION;INTRAMUSCULAR - EQ 10MG BASE/VIAL
FOR SUSPENSION;INTRAMUSCULAR - EQ 20MG BASE/VIAL
FOR SUSPENSION;INTRAMUSCULAR - EQ 30MG BASE/VIAL
FOR SUSPENSION;INTRAMUSCULAR - EQ 40MG BASE/VIAL
FOR SUSPENSION;INTRAMUSCULAR - EQ 60MG BASE/VIAL

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

globalSalesInformation
1 US Medicaid Prescriptions

PATENTS & EXCLUSIVITIES

15 US Patents, 5 US Exclusivities, 12 Health Canada Patents

patents
15 US Patents
5 US Exclusivities
12 Health Canada Patents

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

3,666,524

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Pasireotide embonate, Som230 pamoate, Som-230 pamoate, Pasireotide (pamoate), Signifor lar, 396091-79-5 (pamoate)

Molecular Formula

C₈₁H₈₂N₁₀O₁₅

Molecular Weight

1435.6 g/mol

InChI Key

HSXBEUMRBMAVDP-QKXVGOHISA-N

FDA UNII

04F55A7UZ3

1 2D Structure

Pasireotide Pamoate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[(3S,6S,9S,12R,15S,18S,20R)-9-(4-aminobutyl)-3-benzyl-12-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-6-[(4-phenylmethoxyphenyl)methyl]-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl] N-(2-aminoethyl)carbamate;4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid

2.1.2 InChI

InChI=1S/C58H66N10O9.C23H16O6/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45;24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72);1-10,24-25H,11H2,(H,26,27)(H,28,29)/t43-,46+,47+,48-,49+,50+,51+;/m1./s1

2.1.3 InChI Key

HSXBEUMRBMAVDP-QKXVGOHISA-N

2.1.4 Canonical SMILES

C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O

2.1.5 Isomeric SMILES

C1[C@H](CN2[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O

2.2 Other Identifiers

2.2.1 UNII

04F55A7UZ3

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Pasireotide Embonate

2. Som230 Pamoate

3. Som-230 Pamoate

4. Pasireotide (pamoate)

5. Signifor Lar

6. 396091-79-5 (pamoate)

7. 396091-79-5

8. 04f55a7uz3

9. Cyclo((2s)-2-phenylglycyl-d-tryptophyl-l-lysyl-o-(phenylmethyl)-l-tyrosyl-l-phenylalanyl-(4r)-4-((((2-aminoethyl)amino)carbonyl)oxy)-l-prolyl), 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylate) (1:1)

10. (3s,6r,9s,12s,15s,19r,20as)-6-((1h-indol-3-yl)methyl)-9-(4-aminobutyl)-15-benzyl-12-(4-(benzyloxy)benzyl)-1,4,7,10,13,16-hexaoxo-3-phenylicosahydropyrrolo[1,2-a][1,4,7,10,13,16]hexaazacyclooctadecin-19-yl (2-aminoethyl)carbamate 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylate)

11. Pasireotide Pamoate [jan]

12. Unii-04f55a7uz3

13. Pasireotide Embonate [who-dd]

14. Pasireotide Pamoate [orange Book]

15. Hy-108768

16. Cs-0031013

17. Q27247644

18. [(3s,6s,9s,12r,15s,18s,20r)-9-(4-aminobutyl)-3-benzyl-12-(1h-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-6-[(4-phenylmethoxyphenyl)methyl]-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl] N-(2-aminoethyl)carbamate;4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid

2.4 Create Date

2007-01-09

3 Chemical and Physical Properties

Molecular Formula	C₈₁H₈₂N₁₀O₁₅
Molecular Weight	1435.6 g/mol
Hydrogen Bond Donor Count	13
Hydrogen Bond Acceptor Count	17
Rotatable Bond Count	22
Exact Mass	1434.59611195 g/mol
Monoisotopic Mass	1434.59611195 g/mol
Topological Polar Surface Area	396 Å²
Heavy Atom Count	106
Formal Charge	0
Complexity	2510
Isotope Atom Count	0
Defined Atom Stereocenter Count	7
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2